Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04767854 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Digital Osteoarthritis Care

Study acronym: DigiOA
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 156 to confirmed 68
    • Study sites: 14 to 13
    • Study completion date: Dec 31, 2024 to Dec 31, 2025
    v13
  2. Minor Re-verified, no change to tracked fieldsv12
  3. Notable Lead sponsor: National Resource Center for Rehabilitation in Rheumatology to Diakonhjemmet Hospital
    • Primary completion date: Dec 31, 2022 to Dec 31, 2023
    • Study completion date: Apr 1, 2023 to Dec 31, 2024
    v11
  4. Notable Primary completion date: Jul 1, 2022 to Dec 31, 2022v10
  5. Minor Secondary endpoints: details revised at 16 of 49 entriesv9
Show 7 earlier versionsHide 7 earlier versions
  1. Minor Study sites: 12 to 14v8
  2. Minor Secondary endpoints revised (49)
    • Site details revised at 1 of 12 sites
    v7
  3. Minor Secondary endpoints: 46 to 49v6
  4. Minor Study sites: 8 to 12v5
  5. Minor Site details revised at 3 of 8 sitesv4
  6. Minor Study sites revised (8)v3
  7. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 8
    • Start date changed from estimate of Apr 1, 2021 to Jun 1, 2021
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Osteoarthritis (OA) is among the most prevalent and costly diseases, with an estimate of $460 billion in all-cause medical costs. It causes pain and reduced physical function, and with no existing cure, the recommended first-line treatment is information, exercise and weight management if indicated. As the prevalence of OA is expected to increase in the coming years, exploring innovative solutions to maintain economical sustainable treatment in the future becomes a necessity. Telerehabilitation, technology which involves providing treatment through information and communication technology, regardless of the patient's geographical location, has shown its potential within cardiac, pulmonary, neurological and musculoskeletal conditions. Virtual Training (VT) is a generic mobile health application used to deliver digital home exercise programs with text, audio and video support. Through a novel feedback system the therapist is able monitor the patients progress and pain level during exercise. This project aims to investigate, through a randomized controlled trial (RCT), whether the use of the VT-app is as effective as supervised exercise therapy in improving pain, physical function and disease activity in patients with hip and/or knee osteoarthritis. In addition, the investigators want to investigate if the use of the app is more cost effective than supervised exercise therapy, whether the use increases adherence with first line treatment, and whether there are certain characteristics of the patients responding to the intervention.
Trial Details
NCT Number NCT04767854
Lead Sponsor Diakonhjemmet Hospital
Collaborators: The Dam Foundation, The Norwegian Council for Musculoskeletal Health
Conditions
(from sponsor)
Osteoarthritis
Related terms Osteoarthritis
Enrollment 68 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov